Related Experiment Video
Updated: Jun 12, 2026
05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
Implementing Same-Day Long-Acting Injectable PrEP: A Program Brief Highlighting Integrated and Rapid HIV Prevention
Crystal Walker1,2,3,4, Sonia Manjarrez Yanez1,2,3,4, Alex Gallardo1,2,3,4
1Crystal Walker, PhD, DNP, FNP-C, is an APRN and Associate Director of The Sexual Health Program at CommUnityCare Health Centers, Austin, Texas, USA.
Summary
A Southern U.S. community health center successfully implemented a same-day long-acting injectable PrEP (LAI-PrEP) program. This model rapidly transitioned patients from oral PrEP to LAI-PrEP, demonstrating feasibility and patient preference for HIV prevention.
Area of Science:
- Public Health
- HIV Prevention
- Implementation Science
Background:
- Oral pre-exposure prophylaxis (PrEP) is effective but adherence can be challenging.
- Long-acting injectable PrEP (LAI-PrEP) offers an alternative with potential for improved adherence.
- Implementing new HIV prevention modalities requires careful planning and execution.
Purpose of the Study:
- To detail the implementation of a same-day LAI-PrEP program at a community health center.
- To assess the feasibility and patient acceptance of rapid transition to LAI-PrEP.
- To identify key components for scaling up timely HIV prevention interventions.
Main Methods:
- Established interdisciplinary coordination among healthcare staff.
- Optimized clinical protocols for same-day LAI-PrEP initiation.
- Ensured access to sample medication for immediate patient use.
Main Results:
- Achieved successful same-day transition from oral PrEP to LAI-PrEP within 2 hours.
- Demonstrated the feasibility of the same-day LAI-PrEP model.
- Confirmed alignment of the program with patient preferences.
Conclusions:
- Same-day LAI-PrEP is a feasible and patient-centered model for HIV prevention.
- Effective implementation requires interdisciplinary collaboration and streamlined protocols.
- This model offers actionable insights for reducing HIV disparities and enhancing intervention uptake.
Keywords:
care coordinationimplementation practicepreexposure prophylaxisrapid initiation modelsworkflow integrationMore Related Videos
Related Concept Videos
01:27Insulin Formulations: Types and Delivery
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into rapid-acting...
Short-acting insulins are divided into rapid-acting...
01:11Oral Drug Delivery Systems: Delayed-Release Systems
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:22Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
01:21Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
01:21Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...